In a multi-center, double-blind study, Lumenis recently received FDA approval of its OptiLight with Intense Pulse Light (IPL). This joins a long list of clinical studies showing its safety and efficacy.
Our dry eye patients embrace this novel and modern approach to managing their condition(s). Since dry eye disease is a multi-factorial disease, we need a treatment option that provides a multi-factorial solution. In our practice, OptiLight has become a foundational treatment option to give patients' lasting relief.
How Does it Work?
1. OptiLight breaks the dry eye vicious cycle of inflammation by reducing major sources of inflammation leading to dry eye disease such as abnormal blood vessels, Demodex mites, and pro-inflammatory agents.
2. OptiLight restores the function of meibomian glands and improves tear break up time.
What Should I Expect?
The treatment protocol typically consists of 4 sessions, about 2 to 4 weeks apart:.
Who is a candidate for Optilight?
You may benefit from OptiLight if you have symptoms such as dryness, grittiness, watery eyes, lid infections, sties, red eyes, eye fatigue, itchy eyes, and fluctuating or blurry vision. Additionally, ask about OptiLight, if you have been diagnosed with one or more of the following: dry eye disease, MGD, blepharitis, ocular rosacea, chalazion, or hordeolum.